SCHEMBL24288107

SCHEMBL24288107

Cc1nc(NC2CCCC(N(C)C)C2)nnc1-c1ccc(F)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 1/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ PAK4 O96013 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ CSNK1A1 P48729 1/20 0.38
▸ CDK8 P49336 1/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ CDK7 P50613 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ PRKX P51817 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ MAP4K2 Q12851 1/20 0.38
▸ STK3 Q13188 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30838024 1.00 CDC7 (0.38) CDC7DAPK3ROCK2MAP4K4PAK4
SCHEMBL30838096 0.83 CDK2 (0.40) CDC7DAPK3ROCK2MAP4K4PAK4
SCHEMBL30837994 0.74 MAPK8 (0.39) MAP4K4DPP4MAPK14MAPK8MCHR1
Hydrochloric Acid SCHEMBL30838027 0.73 MAPK8 (0.39) MAP4K4DPP4MAPK14MAPK8MCHR1
SCHEMBL30054913 0.70 NLRP3 (0.60) NLRP3
SCHEMBL29159535 0.70 NLRP3 (0.60) NLRP3
SCHEMBL30375405 0.69 IL1B (0.52) NLRP3
SCHEMBL30684741 0.69 IL1B (0.52) NLRP3
SCHEMBL26092873 0.69 IL1B (0.52) NLRP3
SCHEMBL27182193 0.69 IL1B (0.52) NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053823-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR Cerevance, Inc. (US) 2022-03-17 — — WO disclosed
Send feedback